Aerobic Versus Anaerobic Exercise on Immune Functions and Disease Severity in Patients With COVID-19
Aerobic Versus Anaerobic Exercise on Immune Functions and Disease Severity in Patients With COVID-19: A Randomized Control Trial
Sponsor: Istanbul Gelisim University
A NA clinical study on Covid19 and Immune Response, this trial is ongoing. The trial is conducted by Istanbul Gelisim University and has accumulated 5 data snapshots since 2021. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
5 versions recorded-
Sep 2025 — Present [monthly]
Unknown NA
-
Sep 2024 — Sep 2025 [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Sep 2023 — Jul 2024 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Sep 2021 — Sep 2023 [monthly]
Recruiting NA
First recorded
Jan 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Istanbul Gelisim University
For direct contact, visit the study record on ClinicalTrials.gov .